SCHEMBL19329686

SCHEMBL19329686

NC(=O)c1cc(S(=O)(=O)Nc2ccc(OCc3ccccc3)cc2)ccc1O

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
PKM P14618 1/20 0.69
AR P10275 8/20 0.62
POLB P06746 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
PGR P06401 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.57
SIRT2 Q8IXJ6 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 1/20 0.53
ACLY P53396 1/20 0.53
PTGES2 Q9H7Z7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375202 0.91 MEN1 (0.78) MEN1KMT2APKMARPOLB
SCHEMBL19329721 0.85 MCL1 (0.63) MEN1KMT2APGRSMN1; SMN2KDM4E
SCHEMBL19329415 0.84 ALDH1A1 (0.60) MEN1KMT2APKMPOLBSMN1; SMN2
SCHEMBL5371903 0.81 MEN1 (0.77) MEN1KMT2APKMARPOLB
SCHEMBL5380382 0.81 MEN1 (0.77) MEN1KMT2APKMARPOLB
SCHEMBL19329343 0.81 SMN1; SMN2 (0.58) MEN1KMT2APKMARPOLB
SCHEMBL19329385 0.81 ALDH1A1 (0.56) MEN1KMT2APKMARPOLB
SCHEMBL19329631 0.80 POLB (0.64) MEN1KMT2APKMPOLBPGR
SCHEMBL5373189 0.80 MEN1 (0.77) MEN1KMT2APKMARPOLB
SCHEMBL5378751 0.79 MEN1 (0.72) MEN1KMT2APKMARPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017153952-A1 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-14 WO claimed
WO-2017153952-A1 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-14 WO disclosed